Research: “MOG-Spectrum Diseases in children: Longterm outcome, radiological features, treatment aspects, biomarkers of disease activity”.

Zuweisungsformular für Patienten

PI: K. Rostásy, Vestische Kinder- und Jugendklinik Datteln, Germany; E-Mail: k.rostasy(at)

M. Reindl, Neuroimmunology, Medical University Innsbruck, Austria;
Co-Investigators: M. Baumann, C. Lechner, Children´s Hospital Innsbruck, Austria; ch.lechner(at) 

E. Wendel Children´s Hospital Stuttgart, Germany; e.wendel(at)
I. Naggar, Vestische Kinder- und Jugendklinik Datteln, Germany

Collaborators: T. Chinits, Pediatric Neurology, MGH, Boston, USA;
R. Höftberger, Neuropathology, Medical University Vienna, Austria;
C. Finke, Neurology, Charité, Berlin, Germany.


Publications 2018- 2019


  • Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases. Hofer LS, et al. Mult Scler J Exp Transl Clin. 2019 May 15;5(2):2055217319848463 2.
  • N-Methyl-D-Aspartate Receptor Encephalitis with Psychiatric Symptoms and an Ovarian Teratoma Detected by MRI in a 17-Year-Old Girl. Barth A, et al. Neuropediatrics. 2019 Jun 4. [Epub ahead of print]
  • NFL is a marker of treatment response in children with SMA treated with nusinersen.
  • Olsson B, et al. J Neurol. 2019 May 23. [Epub ahead of print]
  • Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. Waubant E, et al. IPMSSG. Neurology. 2019 May 28;92(22):e2538-e2549. 
  • Childhood multiple sclerosis is associated with reduced brain volumes at first clinical presentation and brain growth failure. Bartels F, et al. Mult Scler. 2019 Jun;25(7):927-936. 
  • Pattern of myogenesis and vascular repair in early and advanced lesions of juvenile dermatomyositis. Baumann M, et al. Neuromuscul Disord. 2018 Dec;28(12):973-985. 
  • Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis. Chitnis T, et al. PARADIGMS Study Group.N Engl J Med. 2018 Sep 13;379(11):1017-1027. 
  • Clinical and magnetic resonance imaging features of children, adolescents, and adults with a clinically isolated syndrome. Milos RI, et al. Eur J Paediatr Neurol. 2018 Nov;22(6):1087-1094. 
  • Angelman Syndrome-Affected Individual with a Numerically Normal Karyotype and Isodisomic Paternal Uniparental Disomy of Chromosome 15 due to Maternal Robertsonian Translocation (14;15) by Monosomy Rescue. Bramswig NC, et al. Cytogenet Genome Res. 2018 Jul 18. 
  • Immune-mediated ataxias. Joubert B, Rostásy K, Honnorat J.
  • Handb Clin Neurol. 2018;155:313-332. doi: 10.1016/B978-0-444-64189-2.00021-4. Review.
  • Paediatric multiple sclerosis and other acute demyelinating diseases. Rostásy K, Bajer-Kornek B.Curr Opin Neurol. 2018 Jun;31(3):244-248. 
  • Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Mueller SH, et al and the  German Network for Research on Autoimmune Encephalitis (GENERATE). Ann Neurol. 2018 Apr;83(4):863-869. 
  • Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome. Wong YYM, et al.Eur J Neurol. 2018 May;25(5):782-786. 
  • MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein. Baumann M, et al. J Neurol. 2018 Apr;265(4):845-855.   

Impressum | Datenschutz- und Nutzungsbedingungen